285 related articles for article (PubMed ID: 15809489)
1. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
Yagle KJ; Eary JF; Tait JF; Grierson JR; Link JM; Lewellen B; Gibson DF; Krohn KA
J Nucl Med; 2005 Apr; 46(4):658-66. PubMed ID: 15809489
[TBL] [Abstract][Full Text] [Related]
2. Imaging apoptosis in vivo using 124I-annexin V and PET.
Keen HG; Dekker BA; Disley L; Hastings D; Lyons S; Reader AJ; Ottewell P; Watson A; Zweit J
Nucl Med Biol; 2005 May; 32(4):395-402. PubMed ID: 15878509
[TBL] [Abstract][Full Text] [Related]
3. 18F-labelled annexin V: a PET tracer for apoptosis imaging.
Murakami Y; Takamatsu H; Taki J; Tatsumi M; Noda A; Ichise R; Tait JF; Nishimura S
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):469-74. PubMed ID: 14666384
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
Tait JF; Smith C; Blankenberg FG
J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
[TBL] [Abstract][Full Text] [Related]
5. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET.
Dekker B; Keen H; Lyons S; Disley L; Hastings D; Reader A; Ottewell P; Watson A; Zweit J
Nucl Med Biol; 2005 Apr; 32(3):241-52. PubMed ID: 15820759
[TBL] [Abstract][Full Text] [Related]
6. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
[TBL] [Abstract][Full Text] [Related]
8. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent.
Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z
Molecules; 2015 Mar; 20(3):4902-14. PubMed ID: 25789822
[TBL] [Abstract][Full Text] [Related]
9. Imaging of apoptosis (programmed cell death) with 99mTc annexin V.
Blankenberg FG; Katsikis PD; Tait JF; Davis RE; Naumovski L; Ohtsuki K; Kopiwoda S; Abrams MJ; Strauss HW
J Nucl Med; 1999 Jan; 40(1):184-91. PubMed ID: 9935075
[TBL] [Abstract][Full Text] [Related]
10. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
[TBL] [Abstract][Full Text] [Related]
13. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
[TBL] [Abstract][Full Text] [Related]
14. Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124.
Dekker B; Keen H; Shaw D; Disley L; Hastings D; Hadfield J; Reader A; Allan D; Julyan P; Watson A; Zweit J
Nucl Med Biol; 2005 May; 32(4):403-13. PubMed ID: 15878510
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods.
Tait JF; Smith C; Levashova Z; Patel B; Blankenberg FG; Vanderheyden JL
J Nucl Med; 2006 Sep; 47(9):1546-53. PubMed ID: 16954565
[TBL] [Abstract][Full Text] [Related]
16. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C
J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682
[TBL] [Abstract][Full Text] [Related]
17. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.
Taki J; Higuchi T; Kawashima A; Fukuoka M; Kayano D; Tait JF; Matsunari I; Nakajima K; Kinuya S; Strauss HW
J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551
[TBL] [Abstract][Full Text] [Related]
18. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
[TBL] [Abstract][Full Text] [Related]
20. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V.
Taki J; Higuchi T; Kawashima A; Tait JF; Kinuya S; Muramori A; Matsunari I; Nakajima K; Tonami N; Strauss HW
J Nucl Med; 2004 Sep; 45(9):1536-41. PubMed ID: 15347721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
